Literature DB >> 34669124

SGK1, autophagy and cancer: an overview.

Madiha Javeed Ghani1.   

Abstract

BACKGROUND: The serum and glucocorticoid-induced kinase-1 (SGK1) belonging to the AGC protein kinase family phosphorylates serine and threonine residues of target proteins. It regulates numerous ion channels and transporters and promotes survival under cellular stress. Unique to SGK1 is a tight control at transcriptional and post-transcriptional levels. SGK1 regulates multiple signal transduction pathways related to tumor development. Several studies have reported that SGK1 is upregulated in different types of human malignancies and induces resistance against inhibitors, drugs, and targeted therapies. RESULTS AND
CONCLUSION: This review highlights the cellular functions of SGK1, its crucial role in cancer development, and clinical insights for SGK1 targeted therapies. Furthermore, the role of SGK1-mediated autophagy as a potential therapeutic target for cancer has been discussed.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Autophagy; Cancer; Inhibitors; SGK1; Tumorigenesis

Mesh:

Substances:

Year:  2021        PMID: 34669124     DOI: 10.1007/s11033-021-06836-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  77 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  High frequency of mutations of the PIK3CA gene in human cancers.

Authors:  Yardena Samuels; Zhenghe Wang; Alberto Bardelli; Natalie Silliman; Janine Ptak; Steve Szabo; Hai Yan; Adi Gazdar; Steven M Powell; Gregory J Riggins; James K V Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Science       Date:  2004-03-11       Impact factor: 47.728

Review 3.  The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies.

Authors:  Lavanya Kondapalli; Keyoumars Soltani; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2005-08       Impact factor: 11.527

Review 4.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.

Authors:  Jeffrey A Engelman; Ji Luo; Lewis C Cantley
Journal:  Nat Rev Genet       Date:  2006-08       Impact factor: 53.242

5.  Role of brain aldosterone and mineralocorticoid receptors in aldosterone-salt hypertension in rats.

Authors:  H-W Wang; B S Huang; A Chen; M Ahmad; R A White; F H H Leenen
Journal:  Neuroscience       Date:  2015-11-30       Impact factor: 3.590

6.  Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume.

Authors:  S Waldegger; P Barth; G Raber; F Lang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

Review 7.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 8.  (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms.

Authors:  Florian Lang; Christoph Böhmer; Monica Palmada; Guiscard Seebohm; Nathalie Strutz-Seebohm; Volker Vallon
Journal:  Physiol Rev       Date:  2006-10       Impact factor: 37.312

9.  Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum.

Authors:  M K Webster; L Goya; Y Ge; A C Maiyar; G L Firestone
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

10.  3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.

Authors:  Matthew Maurer; Tao Su; Lao H Saal; Susan Koujak; Benjamin D Hopkins; Christina R Barkley; Jiaping Wu; Subhadra Nandula; Bhaskar Dutta; Yuli Xie; Y Rebecca Chin; Da-In Kim; Jennifer S Ferris; Sofia K Gruvberger-Saal; Mervi Laakso; Xiaomei Wang; Lorenzo Memeo; Albert Rojtman; Tulio Matos; Jennifer S Yu; Carlos Cordon-Cardo; Jorma Isola; Mary Beth Terry; Alex Toker; Gordon B Mills; Jean J Zhao; Vundavalli V V S Murty; Hanina Hibshoosh; Ramon Parsons
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

View more
  1 in total

1.  SGK1 in Cancer: Biomarker and Drug Target.

Authors:  Jonas Cicenas; Edita Meskinyte-Kausiliene; Vigilijus Jukna; Arnas Rimkus; Jokubas Simkus; Diana Soderholm
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.